
Loading, please wait...

Loading, please wait...

A review determined the benefit of vedolizumab and TNF-α inhibitors in patients with steroid-refractory microscopic colitis (MC) in 14 studies involving 164 patients. Results exhibited a clinical remission rate of 63.5%, 57.8% & 39.3% for vedolizumab, infliximab, and adalimumab, respectively. Discontinuation of therapy due to biological adverse events was 12.2%, 32.9%, and 23% for vedolizumab, infliximab, and adalimumab groups, respectively.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A review determined the benefit of vedolizumab and TNF-α inhibitors in patients with steroid-refractory microscopic colitis (MC) in 14 studies involving 164 patients. Results exhibited a clinical remission rate of 63.5%, 57.8% & 39.3% for vedolizumab, infliximab, and adalimumab, respectively. Discontinuation of therapy due to biological adverse events was 12.2%, 32.9%, and 23% for vedolizumab, infliximab, and adalimumab groups, respectively.
3 months ago

A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today

Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today

This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday